NCT03096431

Brief Summary

To determine the feasibility of processes and instruments with an overarching purpose to guide the design of a larger study. To determine the feasibility of individuals with metastatic brain tumor(s) to engage in physical activity(PA) and cognitive rehabilitation (CR) as in an outpatient therapy setting.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 23, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 30, 2017

Completed
5 months until next milestone

Study Start

First participant enrolled

September 1, 2017

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 9, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 9, 2018

Completed
Last Updated

July 13, 2018

Status Verified

July 1, 2018

Enrollment Period

10 months

First QC Date

March 23, 2017

Last Update Submit

July 11, 2018

Conditions

Keywords

whole-brain radiation therapysterotactic radiosurgerycognitive rehabilitationphysical activity

Outcome Measures

Primary Outcomes (6)

  • Recruitment percentage of eligible subjects.

    Recruitment: success defined as enrollment rate of 19% of eligible subjects.

    18.5 months

  • Retention percentage of participants at end-of-study.

    Retention: success defined as retention rate above 56% at end-of-study.

    18.5 months

  • Non-attendance rates of participants. instructions.

    Participant missed or cancelled therapy sessions less than 15% of time.

    18.5 months

  • Lengths of sessions completed.

    Participant completed full scheduled minutes per session ≥ 80% of time.

    18.5 months

  • Percentage of completion of Physical Activity intervention tasks.

    Participant completed ≥ 80% of PA interventions (required \< 20% rest period during or between tasks).

    18.5 months

  • Percentage of Cognitive Therapy intervention tasks.

    Participant completed ≥ 80% of CR interventions (required \< 20% rest period during or between tasks).

    18.5 months

Secondary Outcomes (2)

  • Change in cognitive abilities.

    18.5 months

  • Change in physical abilities.

    18.5 months

Study Arms (3)

Arm 1: Physical activity intervention

ACTIVE COMPARATOR

Undergo baseline testing of physical (lower body strength, endurance) and cognitive (executive functioning) abilities. 14 days (± 2 days) following WBRT/SRS: all arms undergo testing of physical (lower body strength, endurance) and cognitive (executive functioning) abilities. Arm 1: intervention of physical activity begins. 60 days (± 5 days) post testing after WBRT/SRS: all arms undergo final testing of physical (lower body strength, endurance) and cognitive (executive functioning) abilities.

Behavioral: Physical Activity

Arm 2:Physical activity and cognitive intervention

ACTIVE COMPARATOR

Undergo baseline testing of physical (lower body strength, endurance) and cognitive (executive functioning) abilities. 14 days (± 2 days) following WBRT/SRS: all arms undergo testing of physical (lower body strength, endurance) and cognitive (executive functioning) abilities. Arm 2: intervention of both cognitive rehabilitation and physical activity begins. 60 days (± 5 days) post testing after WBRT/SRS: all arms undergo final testing of physical (lower body strength, endurance) and cognitive (executive functioning) abilities.

Behavioral: Physical ActivityBehavioral: Cognitive rehabilitation

Arm 3: Cognitive and begin physical activity intervention

ACTIVE COMPARATOR

Undergo baseline testing of physical (lower body strength, endurance) and cognitive (executive functioning) abilities. Arm 3: Intervention of cognitive rehabilitation begins prior to and is concurrent with WBRT/SRS treatment. 14 days (± 2 days) following WBRT/SRS: all arms undergo testing of physical (lower body strength, endurance) and cognitive (executive functioning) abilities. Arm 3: continue intervention of cognitive rehabilitation; add intervention of physical activity. 60 days (± 5 days) post testing after WBRT/SRS: all arms undergo final testing of physical (lower body strength, endurance) and cognitive (executive functioning) abilities.

Behavioral: Physical ActivityBehavioral: Cognitive rehabilitation

Interventions

* Self-exercise: number of steps per day, per fitness tracker; self-report of daily activity. * One-to-one intervention: 30 minute sessions with licensed therapist to include warm-up, generalized strengthening, stretching.

Also known as: PA
Arm 1: Physical activity interventionArm 2:Physical activity and cognitive interventionArm 3: Cognitive and begin physical activity intervention

One-to-one intervention: 45 minutes sessions with licensed therapist to include graded cognitive tasks designed to improve executive functioning with focus on both restorative and compensatory approaches.

Also known as: CR, Cognitive retraining
Arm 2:Physical activity and cognitive interventionArm 3: Cognitive and begin physical activity intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ability to understand and the willingness to provide written informed consent
  • years of age and older
  • Diagnosed with one or more metastatic brain tumor(s)
  • Medical treatment plan includes whole-brain radiation therapy and / or sterotactic radiosurgery

You may not qualify if:

  • Diagnosis of dementia or unable to grant their own informed consent
  • Prisoner or patient in custody
  • Patient on psychiatric hold
  • Physically unable to participate in the study
  • The opinion of the treating physician determines it is not medically safe to participate in the study
  • Pre-registration screen of cognition is "severe" or lower.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Virginia Commonwealth University/Massey Cancer Center

Richmond, Virginia, 23298-0037, United States

Location

MeSH Terms

Conditions

Brain NeoplasmsMotor Activity

Interventions

ExerciseCognitive Training

Condition Hierarchy (Ancestors)

Central Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteNeoplasmsBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaNeurological RehabilitationRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Suzanne F. Taylor, PhD, MBA, OTR/L

    Virginia Commonwealth University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
All participants will be blinded to the study design and will be randomized into one of three treatment arms. Research assistant is blinded to both the study design and to which arm the participants are randomized.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 23, 2017

First Posted

March 30, 2017

Study Start

September 1, 2017

Primary Completion

July 9, 2018

Study Completion

July 9, 2018

Last Updated

July 13, 2018

Record last verified: 2018-07

Locations